Fasting Study of Metolazone Tablets 2.5 mg and Zaroloxyn® Tablets 2.5 mg
NCT00649051
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
52
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Metolazone Tablets 2.5 mg
DRUG:
Zaroloxyn® Tablets 2.5 mg
Sponsor
Mylan Pharmaceuticals Inc